Valuation : Yuhan Corporation

Market Cap 6,021B 4.47B 3.85B 3.62B 3.3B 6.18B 423B 6.2B 42.89B 16.58B 217B 16.79B 16.43B 690B P/E 2026 *
40.5x
P/E 2027 * 29.3x
Enterprise Value 5.94B 4.41M 3.79M 3.57M 3.26M 6.09M 417M 6.11M 42.32M 16.36M 214M 16.57M 16.21M 681M EV / Sales 2026 *
2.54x
EV / Sales 2027 * 2.29x
Free-Float
61.43%
Yield 2026 *
0.7%
Yield 2027 * 0.71%
1 day-0.86%
1 week-4.95%
Current month-3.58%
1 month+3.73%
3 months+4.13%
6 months-18.73%
Current year-28.20%
1 week 80,000
Extreme 80000
84,700
1 month 77,500
Extreme 77500
87,500
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.86%-4.95%-32.18%+19.51% 4.51B
-1.32%+1.33%+77.46%+41.17% 371B
-0.55%-3.67%+23.32%-19.42% 68.64B
-0.51%+4.59%+47.06%+168.63% 12.51B
-0.56%-10.27%-8.78%-9.42% 8.06B
-1.85%-3.41%-22.16%+4.17% 5.04B
-1.39%-4.45%-34.69%-0.21% 3.07B
-1.00%-0.46%-5.37%+37.45% 2.53B
-0.77%-4.73%-24.93%-17.26% 2B
-0.24%-2.19%-25.24%-14.10% 1.7B
Average -0.90%-2.16%-0.55%+21.05% 47.89B
Weighted average by Cap. -1.17%+0.43%+63.43%+33.64%

Financials

2026 *2027 *
Net sales 2,340B 1.74B 1.49B 1.41B 1.28B 2.4B 164B 2.41B 16.67B 6.44B 84.18B 6.53B 6.38B 268B 2,556B 1.9B 1.63B 1.54B 1.4B 2.62B 179B 2.63B 18.2B 7.04B 91.92B 7.13B 6.97B 293B
Net income 154B 114M 98.19M 92.35M 84.3M 158M 10.8B 158M 1.09B 423M 5.53B 429M 419M 17.61B 206B 153M 132M 124M 113M 211M 14.47B 212M 1.47B 567M 7.41B 574M 562M 23.6B
Net Debt -80.13B -59.51M -51.18M -48.14M -43.94M -82.18M -5.63B -82.45M -571M -221M -2.88B -223M -219M -9.18B -162B -120M -103M -97.21M -88.74M -166M -11.37B -167M -1.15B -446M -5.82B -451M -441M -18.54B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-09-07 ₩80,700.00 -0.86% 178,343
26-09-04 ₩81,400.00 0.00% 108,985
26-09-03 ₩81,400.00 +0.12% 256,221
26-09-02 ₩81,300.00 -1.69% 188,082
26-09-01 ₩82,700.00 -1.19% 136,338
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
80,700.00KRW
Average target price
120,111.11KRW
Spread / Average Target
+48.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!